SNCA and Parkinson disease: One study revealed that baicalin (25 mg/kg bodyweight) significantly mitigated 6-hydroxydopamine (6-OHDA)-induced neuronal apoptosis in PD rats and downregulated the expression of Snca, Mtor, Akt1, and Gsk3b in rats.